郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.

期刊:Molecular pharmacology发表年份:2013作者:Peter Keov; Celine Valant; Shane M Devine; J Robert Lane; Peter J Scammells; Patrick M Sexton; Arthur Christopoulos

药效评价Direct cytosolic delivery of polar cargo to cells by spontaneous membrane-translocating peptides.

期刊:The Journal of biological chemistry发表年份:2013作者:Jing He; W Berkeley Kauffman; Taylor Fuselier; Somanna K Naveen; Thomas G Voss; Kalina Hristova; William C Wimley

药效评价Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.

期刊:Molecular pharmacology发表年份:2013作者:J Robert Lane; Pavel Chubukov; Wei Liu; Meritxell Canals; Vadim Cherezov; Ruben Abagyan; Raymond C Stevens; Vsevolod Katritch

药效评价[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.

期刊:British journal of pharmacology发表年份:2013作者:S Molinari; V Camarda; A Rizzi; G Marzola; S Salvadori; E Marzola; P Molinari; J McDonald; M C Ko; D G Lambert; G Calo'; R Guerrini